Head and Neck Neoplasm Clinical Trial
— MASSCOfficial title:
Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC Study)
NCT number | NCT05011500 |
Other study ID # | CTOR20051GZA |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 1, 2021 |
Est. completion date | May 1, 2022 |
The purpose of this study is to investigate the feasibility of using open masks or no masks in combination with optical surface scanning for radiotherapy in patients with head and neck cancer.
Status | Recruiting |
Enrollment | 24 |
Est. completion date | May 1, 2022 |
Est. primary completion date | May 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients = 18 years old - Histologically confirmed head and neck cancer. - Patients treated with radiotherapy (RT) as primary treatment. - An Eastern Cooperative Oncology Group (ECOG) Performance Status grade of 0-1 as defined in Appendix 3. - Each subject must sign an informed consent form (ICF) indicating that he understands the purpose of and procedures required for the study and is willing to participate in the study. - Patients must be willing to comply with treatment plan and other study procedures Exclusion Criteria: - Patients with significantly altered mental status or with psychological, familial, sociological or geographical condition potentially hampering compliance with the study. - Patients who cannot stay still during fraction because of a disorder (e.g. Parkinson's disease) |
Country | Name | City | State |
---|---|---|---|
Belgium | GZA Ziekenhuizen campus Sint-Augustinus | Antwerp |
Lead Sponsor | Collaborator |
---|---|
Cancer Research Antwerp |
Belgium,
Ali I, Matthiesen C, Algan O, Thompson S, Bogardus C, Herman T, Ahmad S. Quantitative evaluation of increase in surface dose by immobilization thermoplastic masks and superficial dosimetry using Gafchromic EBT film and Monte Carlo calculations. J Xray Sci Technol. 2010;18(3):319-26. doi: 10.3233/XST-2010-0263. — View Citation
Bartlett FR, Donovan EM, McNair HA, Corsini LA, Colgan RM, Evans PM, Maynard L, Griffin C, Haviland JS, Yarnold JR, Kirby AM. The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy. Clin Oncol (R Coll Radiol). 2017 Mar;29(3):e51-e56. doi: 10.1016/j.clon.2016.11.005. Epub 2016 Nov 24. — View Citation
Cerviño LI, Pawlicki T, Lawson JD, Jiang SB. Frame-less and mask-less cranial stereotactic radiosurgery: a feasibility study. Phys Med Biol. 2010 Apr 7;55(7):1863-73. doi: 10.1088/0031-9155/55/7/005. Epub 2010 Mar 12. — View Citation
Dekker J, Rozema T, Böing-Messing F, Garcia M, Washington D, de Kruijf W. Whole-brain radiation therapy without a thermoplastic mask. Phys Imaging Radiat Oncol. 2019 Jul 25;11:27-29. doi: 10.1016/j.phro.2019.07.004. eCollection 2019 Jul. — View Citation
Li G, Lovelock DM, Mechalakos J, Rao S, Della-Biancia C, Amols H, Lee N. Migration from full-head mask to "open-face" mask for immobilization of patients with head and neck cancer. J Appl Clin Med Phys. 2013 Sep 6;14(5):243-54. doi: 10.1120/jacmp.v14i5.4400. — View Citation
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7. Erratum in: CA Cancer J Clin. 2014 Sep-Oct;64(5):364. — View Citation
Stieler F, Wenz F, Shi M, Lohr F. A novel surface imaging system for patient positioning and surveillance during radiotherapy. A phantom study and clinical evaluation. Strahlenther Onkol. 2013 Nov;189(11):938-44. doi: 10.1007/s00066-013-0441-z. Epub 2013 Sep 27. — View Citation
van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004 Jan;14(1):52-64. Review. — View Citation
Wiant D, Squire S, Liu H, Maurer J, Lane Hayes T, Sintay B. A prospective evaluation of open face masks for head and neck radiation therapy. Pract Radiat Oncol. 2016 Nov - Dec;6(6):e259-e267. doi: 10.1016/j.prro.2016.02.003. Epub 2016 Feb 13. — View Citation
Zhao B, Maquilan G, Jiang S, Schwartz DL. Minimal mask immobilization with optical surface guidance for head and neck radiotherapy. J Appl Clin Med Phys. 2018 Jan;19(1):17-24. doi: 10.1002/acm2.12211. Epub 2017 Nov 9. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Positional Deviation | Patient positioning and movement during treatment will be assessed using cone-beam computed tomopgraphy (CBCT). The position of the patient and target volumes measured by CBCT will be compared to computed tomography (CT) scans made during the initial simulation of treatment. CBCT-scans are made right before administering radiation and after radiation has been administered. Translational and rotational deviations will be measured and expressed in millimeters (for translational deviation) and degrees (for rotational deviation). | Positional Deviation will be assessed from start of treatment period to end of treatment period (up to 7 weeks). | |
Secondary | Patient Distress | Patient Distress, measured every week using the Subjective Units of Distress Scale (SUDs), a scale of 0-10 where a higher number indicates a worse outcome. | Patient distress will be assessed from start of treatment period to end of treatment period (up to 7 weeks). | |
Secondary | Duration of Treatment | Duration of treatment (in minutes), registered in radiotherapy software. | Duration of treatment will be assessed from start of treatment period to end of treatment period (up to 7 weeks). | |
Secondary | Radiotherapy Technician Satisfaction | Personnel satisfaction, questioned weekly using a personnel satisfaction scale from 0 to 10, where a higher number indicates a better outcome. | Radiotherapy technician satisfaction will be assessed from start of treatment period to end of treatment period (up to 7 weeks). | |
Secondary | Radiation Dose | In vivo dosimetry will be used to asses the accuracy of treatment. Using PerFRACTION™ in vivo dosimetry. Administered radiation doses will be measured for the target volume and expressed in Gray (Gy). | Radiation dose will be assessed from start of treatment period to end of treatment period (up to 7 weeks). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02960308 -
Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
|
||
Terminated |
NCT02602067 -
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
|
Phase 1 | |
Completed |
NCT04277273 -
Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris
|
N/A | |
Completed |
NCT03896906 -
Preoxygenation With a High-flow Nasal Cannula or a Simple Mask Before General Anesthesia in Head and Neck Surgery
|
N/A | |
Completed |
NCT01621295 -
Assessing the Patient Experience in Cancer Care
|
N/A | |
Active, not recruiting |
NCT03854838 -
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
|
Phase 2 | |
Completed |
NCT04151030 -
Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure
|
N/A | |
Completed |
NCT03012581 -
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
|
Phase 2 | |
Active, not recruiting |
NCT04005521 -
Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer
|
N/A | |
Completed |
NCT05590650 -
A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients
|
Phase 1 | |
Terminated |
NCT03402737 -
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N
|
N/A | |
Completed |
NCT04086849 -
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
|
||
Completed |
NCT00001442 -
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
|
Phase 1 | |
Recruiting |
NCT04477759 -
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer
|
Phase 1 | |
Terminated |
NCT00423150 -
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
|
Phase 2 | |
Recruiting |
NCT03757091 -
Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery
|
N/A | |
Recruiting |
NCT04099290 -
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
|
||
Withdrawn |
NCT04679233 -
Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients
|
N/A | |
Not yet recruiting |
NCT04267627 -
Telemedicine Nurse-Led Intervention for Rural Cancer Survivors
|
N/A | |
Completed |
NCT00666926 -
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms
|
Phase 1 |